癌症中的缺血性中风:治疗机制,生物标志物和治疗影响
Gianluca Costamagna1, Babak B Navi2,3, Morin Beyeler4
1Stroke Unit, Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Seminars in thrombosis and hemostasis
|July 28, 2023
概括
癌症患者面临较高的缺血性中风风险,原因是与癌症相关的前血栓状况和治疗的血管毒性. 在这种人群中,个性化策略对于预防和管理中风至关重要.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 血液学 血液学 血液学
背景情况:
- 缺血性中风是癌症患者死亡和残疾的重要原因.
- 癌症和中风之间的联系机制,包括前血栓状况和治疗毒性,是复杂的,并未完全理解.
研究的目的:
- 审查当前有关癌症患者缺血性中风的知识.
- 提出癌症相关中风的分类系统.
- 讨论与癌症有关的中风的生物标志物和管理策略.
主要方法:
- 文献综述总结了有关癌症相关缺血性中风的现有证据.
- 对拟议的病因学分类系统的分析.
- 新生物标志物和当前治疗指南的概述.
主要成果:
- 与癌症相关的前血栓状况和与治疗相关的血管毒性增加了缺血性中风风险.
- 新的生物标记物 (凝血,血小板,内皮标记物,无细胞DNA,细胞外囊泡) 显示出风险分层的潜力.
- 管理与癌症相关的中风需要平衡复发性中风风险与抗血栓治疗导致的出血风险.
结论:
- 对癌症患者来说,预防和治疗中风的个性化方法是必不可少的.
- 需要进行进一步的研究,以澄清中风后恢复癌症治疗的最佳时间.
- 病因分类系统可以帮助鉴定癌症相关中风患者的特征.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis
386
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
386
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


